ADVB Advanced Biomed Inc.

Fundamentals / CIK 0001941029 / USD

Advanced Biomed Inc. reported $128K in revenue and net income of $6.07M for the fiscal year ended June 30, 2026, with a -5337.5% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ADVB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2024 to 2026), reported in USD.

$6.93M$3.46M$0-$3.61MFY 2024 Net Income: -$2.78M2024FY 2025 Net Income: -$3.26M2025FY 2026 Revenue: $128KFY 2026 Net Income: $6.68M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jun 30 Jun 30 Jun 30
Revenue $128K -- --
Research & Development -- $910K $880K
Total Operating Expenses $6.36M $1.09M $2.54M
Operating Income -$6.23M -$1.09M -$2.54M
EBITDA -- -$743K -$2.14M
Interest Income -- $25K $53K
Income Before Tax -$6.26M -$1.09M -$2.78M
Income Tax Expense -$1.2K -- --
Net Income $6.68M -$3.26M -$2.78M
Basic EPS $5.33 -$3.18 -$2.80
Diluted EPS $5.33 -$3.18 -$2.80
Basic Shares Outstanding 1.3M 1.0M 1.0M
Diluted Shares Outstanding 1.3M 1.0M 1.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development -- -- $243K $186K $236K $310K $220K $212K
Total Operating Expenses $974K $5.05M $520K $397K $147K $11K $568K $280K
Operating Income -$974K -$4.92M -$520K -$397K -$147K $227K -$568K -$280K
EBITDA -- -- -$511K -$409K -$99K $502K -$545K -$337K
Interest Income -- -- -- $9.2K $448 $9.5K $26 $15K
Income Before Tax -$989K -$12.52M -$489K $7.00M -$147K $676K -$1.20M -$579K
Net Income -$989K $695K -$489K $6.86M -$387K -$702K -$1.38M -$908K
Basic EPS -$0.60 -- -$0.38 $6.20 -$0.36 -- -$1.35 -$1.00
Diluted EPS -$0.60 -- -$0.38 $6.20 -$0.36 -- -$1.35 -$1.00
Basic Shares Outstanding 1.7M -- 1.3M 1.1M 1.1M -- 1.0M 1.0M
Diluted Shares Outstanding 1.7M -- 1.3M 1.1M 1.1M -- 1.0M 1.0M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jun 30 Jun 30 Jun 30
Cash & Cash Equivalents -- $2.87M $2.61M
Cash & Short-Term Investments -- $2.87M $2.61M
Total Current Assets $13.75M $22.38M $3.05M
Property, Plant & Equipment, Net -- $125K $525K
Intangible Assets -- -- $119K
Other Non-Current Assets -- $2.6K --
Total Non-Current Assets $1.2K $480K $1.41M
Total Assets $13.75M $22.86M $4.46M
Accounts Payable -- $358K $620K
Total Current Liabilities $1.47M $19.24M $2.73M
Total Non-Current Liabilities $0 $146K $65K
Total Liabilities $1.47M $19.38M $2.80M
Total Debt (incl. Leases) -- $42K $127K
Common Stock $1.7K $1.1K $20K
Retained Earnings -$12.56M -$19.23M -$15.97M
Accumulated Other Comp. Income $969K $1.34M $1.12M
Total Stockholders' Equity $12.28M $3.48M $1.66M
Total Equity $12.28M $3.48M $1.66M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- -- -- $2.60M $2.66M $2.87M $5.18M $2.66M
Cash & Short-Term Investments -- -- -- $2.60M $2.66M $2.87M $5.18M $2.66M
Total Current Assets $12.87M $13.75M $10.53M $10.73M $5.84M $22.38M $7.73M $3.14M
Property, Plant & Equipment, Net -- -- $87K $97K $281K $125K $355K $401K
Intangible Assets -- -- -- -- -- -- $20K $51K
Other Non-Current Assets -- -- $2.2K $956 $75K $2.6K -- --
Total Non-Current Assets $35K $1.2K $120K $119K $399K $480K $556K $1.37M
Total Assets $12.90M $13.75M $10.65M $10.85M $6.24M $22.86M $8.29M $4.50M
Accounts Payable -- -- $377K $369K $642K $358K $619K $618K
Other Current Liabilities -- -- -- -- -- -- -- $690K
Total Current Liabilities $1.59M $1.47M $1.43M $1.25M $3.04M $19.24M $4.11M $3.83M
Total Non-Current Liabilities $24K $0 $11K $115K $194K $146K $44K $56K
Total Liabilities $1.61M $1.47M $1.44M $1.37M $3.24M $19.38M $4.16M $3.89M
Total Debt (incl. Leases) $33K -- $30K $21K $31K $42K $183K $290K
Common Stock $1.7K $1.7K $1.4K $22K $22K $1.1K $22K $20K
Retained Earnings -$13.55M -$12.56M -$13.25M -$12.76M -$19.62M -$19.23M -$18.53M -$17.15M
Accumulated Other Comp. Income $969K $969K $844K $875K $1.26M $1.34M $1.29M $1.25M
Total Stockholders' Equity $11.29M $12.28M $9.21M $9.48M $3.00M $3.48M $4.13M $619K
Total Equity $11.29M $12.28M $9.21M $9.48M $3.00M $3.48M $4.13M $619K

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jun 30 Jun 30 Jun 30
Net Income $6.68M -$3.26M -$2.78M
Depreciation & Amortization -- $344K $400K
Stock-Based Compensation $1.73M -- --
Operating Cash Flow -$1.95M -$5.83M -$2.13M
Capital Expenditure -- -$32K -$74K
Free Cash Flow -- -$5.86M -$2.20M
Investing Cash Flow -$2.51M -$32K -$74K
Common Stock Issued $248K $5.49M --
Financing Cash Flow $1.97M $5.93M $1.87M
Net Change in Cash -$2.52M $296K -$14K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$989K $695K -$489K $6.86M -$387K -$702K -$1.38M -$908K
Depreciation & Amortization -- -- $9.3K -$13K $48K $276K $23K -$57K
Operating Cash Flow -$171K -$583K -$240K -$514K -$610K -$1.54M -$3.41M -$842K
Capital Expenditure -- -- -$1.3K -$13K -$1.8K -$20K -$2.2K $11K
Free Cash Flow -- -- -$241K -$526K -$612K -$1.56M -$3.41M -$831K
Investing Cash Flow -- -$2.49M -$1.3K -$13K -$1.8K -$20K -$2.2K $11K
Financing Cash Flow -- $937K $268K $315K $447K -$765K $5.90M $408K
Net Change in Cash -$172K -$2.22M -$2.0K -$46K -$247K -$2.28M $2.53M $10K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jun 30 Jun 30 Jun 30
Operating Margin -4883.8% -- --
Net Profit Margin 5231.3% -- --
Return on Equity (ROE) 54.4% -93.7% -167.3%
Return on Assets (ROA) 48.6% -14.3% -62.4%
Current Ratio 9.33x 1.16x 1.12x
Quick Ratio -- 0.15x 0.95x
Debt to Equity -- 0.01x 0.08x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) 53.8% 54.4% 57.3% 46.3% -112.5% -93.7% -- --
Return on Assets (ROA) 47.1% 48.6% 49.6% 40.4% -54.1% -14.3% -- --
Current Ratio 8.09x 9.33x 7.38x 8.56x 1.92x 1.16x 1.88x 0.82x
Quick Ratio -- -- -- 2.08x 0.87x 0.15x 1.26x 0.69x
Debt to Equity 0.00x -- 0.00x 0.00x 0.01x 0.01x 0.04x 0.47x
Operating Income Growth (YoY) -- -2272.1% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001941029) · from December 31, 2023 Data through September 30, 2026 · synced Nov 21, 2026, 05:10 UTC · Open in terminal